• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natco Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco
  • BSE Code : 4684.0
  • ISIN : INE987B01026
883.40 -10 (-1.15%)
  • As on 01 Jun 2025 (EOD)

  • Today’s Low

    880.35

  • Today’s High

    897.95

  • Open

    890.00

  • Perv Close

    893.70

  • 52W Low

    726.80

  • 52W High

    1,639.00

Key Indicators

  • P/E(TTM)

    8.55

  • Mar.Cap (₹Cr.)

    15,822.57

  • Div & Yield %

    0.68

  • Book Value(₹)

    409.46

  • Debt-Equity Ratio

    -1.15

  • AGM Date

    30-May-2025

  • EPS

    103.31

  • P/E Ratio

    8.55

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    15,822.57

  • RONW (%)

    25.88

  • ROCE (%)

    29.63

Score Board

  • Equity (₹ in Cr.)

    35.82

  • BV (₹)

    409.50

  • Sales( ₹ in Cr.)

    4,094.50

  • NP (in Cr.)

    1,850.40

  • NP Var(%)

    41.0

  • Div%

    300.0

  • CPS (₹)

    115.60

  • EPS (₹)

    103.30

  • Traded Value (₹ in Lakhs)

    15,823.46

  • 52 Week High

    1,639.00

  • 52 Week Low

    726.80

  • Price BSE

    883.0

  • Price NSE

    883.00

  • Market Capital( in Cr.)

    15,823.46

  • P/C Ratio

    7.60

  • P/E Ratio

    8.50

  • Price Vs.BV

    103.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Other Income 104.70 85.50 94.60 101.10 123.80 129.80
Stock Adjustments -17.20 -34.60 5.50 46.90 55.90 25.50
Total Income 3,656.40 2,401.90 1,867.90 1,801.50 1,969.90 2,141.60
EXPENDITURE :            
Raw Materials 557.30 495.10 540.10 546.90 452.90 364.60
Power and Fuel Cost 88.90 81.90 76.40 59.40 62.40 59.60
Employee Cost 454.90 425.70 410.10 380.00 356.10 340.20
Other Manufacturing Expenses 179.80 150.30 148.70 114.30 134.70 119.70
Selling and Administration Expenses 483.70 290.70 309.10 140.30 202.30 253.70
Miscellaneous Expenses 150.10 28.00 75.90 41.90 59.70 57.50
Employee Benefit Expenses 454.90 425.70 410.10 380.00 356.10 340.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,914.70 1,471.70 1,560.30 1,282.80 1,268.10 1,195.30
Operating Profit 1,741.70 930.20 307.60 518.70 701.80 946.30
Interest 14.50 8.60 13.30 11.30 20.60 18.80
Gross Profit 1,727.20 921.60 294.30 507.40 681.20 927.50
Depreciation 171.90 150.90 138.40 115.20 98.10 80.10
Profit Before Tax 1,555.30 770.70 155.90 392.20 583.10 847.40
Current Tax 284.80 133.10 32.50 93.30 129.10 186.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -36.10 0.50 -15.70 -10.60 -20.50 -6.00
Reported Net Profit 1,306.60 637.10 139.10 309.50 474.50 667.10
Extraordinary Items -2.12 14.71 33.80 24.39 12.69 10.53
Adjusted Net Profit 1,308.72 622.39 105.30 285.11 461.81 656.57
Adjustment below Net Profit -49.70 -1.00 0.40 2.20 -31.40 -27.40
P & L Balance brought forward 3,134.60 2,587.10 2,520.50 2,322.50 2,006.80 1,459.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 165.20 88.60 72.90 113.90 127.40 91.90
P & L Balance carried down 4,226.30 3,134.60 2,587.10 2,520.30 2,322.50 2,006.80
Dividend 170.20 100.40 82.10 113.90 127.40 91.90
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 475.00 275.00 225.00 262.50 337.50 312.50
Dividend Per Share(Rs) 9.50 5.50 4.50 5.25 6.75 6.25
Earnings Per Share-Unit Curr 72.99 34.91 7.62 16.96 26.07 36.55
Earnings Per Share(Adj)-Unit Curr 72.99 34.91 7.62 16.96 26.07 36.55
Book Value 312.42 257.64 229.69 224.17 212.61 195.24
Book Value(Adj)-Unit Curr 312.42 257.64 229.69 224.17 212.61 195.24

Shareholding Pattern

  • Promoter Group

    49.56%

  • Public Share Holding

    50.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 746,910 746,910.00 746,910 746,910
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 746,910 0.42 746,910 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 33,070,070 18.46 33,070,070 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,267,145 28.07 50,267,145 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4,686,150 2.62 4,686,150 4
Others 0 0.00 0 0
Sub Total 88,023,365 49.14 88,023,365 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,249 0.00 8,249 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25 0.00 25 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 31,334,279 17.49 31,334,279 292
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,077,813 3.39 6,077,813 18
Mutual Funds / UTI 3,319,025 1.85 3,319,025 54
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 722,384 0.40 722,384 19
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 41,461,775 23.15 41,461,775 385
2] Non Institution
Bodies Corporate 2,931,189 1.64 2,915,589 1,169
Clearing Members 4,713 0.00 4,713 11
Directors of their Relatives 119,923 0.07 119,923 9
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,525,308 1.41 2,524,208 9,465
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,532,374 3.65 6,532,374 21
Individuals holding nominal share capital up to Rs. 1 lakh 35,882,105 20.03 35,494,975 394,131
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,126 0.00 1,126 5
Others 861,482 0.48 861,482 3
Sub Total 48,877,820 27.29 48,473,990 404,815
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 179,109,870 100.00 178,706,040 405,222

Company Background

Natco Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco Pharma Ltd
  • BSE Code : 4684.0
  • ISIN : INE987B01026

  • Incorporation Year

    1981

  • Registered Office

    Natco House
    Road No 2 Banjara Hills, Hyderabad,
    Telangana-500033

  • Telephone

    91-040-23547532

  • FAX

    91-040-23548243

  • Chairman

    V C Nannapaneni

  • Managing Director

    V C Nannapaneni

  • Company Secretary

    Venkat Ramesh

  • Auditor

    B S R & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Natco Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natco Pharma 883.45 3,673.60 3,568.90 8.55 28.58
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92